Folgen
michael zalutsky
michael zalutsky
professor
Bestätigte E-Mail-Adresse bei mc.duke.edu
Titel
Zitiert von
Zitiert von
Jahr
Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas
CJ Wikstrand, LP Hale, SK Batra, ML Hill, PA Humphrey, SN Kurpad, ...
Cancer research 55 (14), 3140-3148, 1995
6521995
Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.
PA Humphrey, AJ Wong, B Vogelstein, MR Zalutsky, GN Fuller, GE Archer, ...
Proceedings of the National Academy of Sciences 87 (11), 4207-4211, 1990
4761990
Clinical experience with α-particle–emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6
MR Zalutsky, DA Reardon, G Akabani, RE Coleman, AH Friedman, ...
Journal of Nuclear Medicine 49 (1), 30-38, 2008
4342008
Pinhole collimation for ultra-high-resolution, small-field-of-view SPECT
RJ Jaszczak, J Li, H Wang, MR Zalutsky, RE Coleman
Physics in Medicine & Biology 39 (3), 425, 1994
3851994
Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia
DE Meyer, GA Kong, MW Dewhirst, MR Zalutsky, A Chilkoti
Cancer research 61 (4), 1548-1554, 2001
3582001
Phase II Trial of Murine 131I-Labeled Antitenascin Monoclonal Antibody 81C6 Administered Into Surgically Created Resection Cavities of Patients With Newly …
DA Reardon, G Akabani, R Edward Coleman, AH Friedman, HS Friedman, ...
Journal of Clinical Oncology 20 (5), 1389-1397, 2002
3262002
A plasmonic gold nanostar theranostic probe for in vivo tumor imaging and photothermal therapy
Y Liu, JR Ashton, EJ Moding, H Yuan, JK Register, AM Fales, J Choi, ...
Theranostics 5 (9), 946, 2015
2922015
Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-α and a mutated form of the …
JH Sampson, G Akabani, GE Archer, DD Bigner, MS Berger, AH Friedman, ...
Journal of neuro-oncology 65, 27-35, 2003
2882003
Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody
D Colcher, M Zalutsky, W Kaplan, D Kufe, F Austin, J Schlom
Cancer research 43 (2), 736-742, 1983
2881983
Astatine-211-labeled radiotherapeutics an emerging approach to targeted alpha-particle radiotherapy
MR Zalutsky, G Vaidyanathan
Current pharmaceutical design 6 (14), 1433-1455, 2000
2602000
The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target
CJ Wikstrand, CJ Reist, GE Archer, MR Zalutsky, DD Bigner
Journal of neurovirology 4 (2), 148-158, 1998
2541998
Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results.
DD Bigner, MT Brown, AH Friedman, RE Coleman, G Akabani, ...
Journal of clinical oncology 16 (6), 2202-2212, 1998
2391998
A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine
MR Zalutsky, AS Narula
International Journal of Radiation Applications and Instrumentation. Part A …, 1987
2391987
Salvage radioimmunotherapy with murine iodine-131–labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase …
DA Reardon, G Akabani, RE Coleman, AH Friedman, HS Friedman, ...
Journal of clinical oncology 24 (1), 115-122, 2006
2252006
A thermally responsive biopolymer for intra-articular drug delivery
H Betre, W Liu, MR Zalutsky, A Chilkoti, VB Kraus, LA Setton
Journal of controlled release 115 (2), 175-182, 2006
2242006
Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors
JH Sampson, G Akabani, GE Archer, MS Berger, RE Coleman, ...
Neuro-oncology 10 (3), 320-329, 2008
2172008
In situ growth of a stoichiometric PEG-like conjugate at a protein's N-terminus with significantly improved pharmacokinetics
W Gao, W Liu, JA Mackay, MR Zalutsky, EJ Toone, A Chilkoti
Proceedings of the National Academy of Sciences 106 (36), 15231-15236, 2009
2142009
Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with α-, β-, and Auger electron–emitting radionuclides
M Boyd, SC Ross, J Dorrens, NE Fullerton, KW Tan, MR Zalutsky, ...
Journal of nuclear medicine 47 (6), 1007-1015, 2006
2022006
Labeling proteins with fluorine-18 using N-succinimidyl 4-[18F] fluorobenzoate
G Vaidyanathan, MR Zalutsky
International journal of radiation applications and instrumentation. Part B …, 1992
2011992
Astatine-211: production and availability
M R Zalutsky, M Pruszynski
Current radiopharmaceuticals 4 (3), 177-185, 2011
1902011
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20